Dose intensity and treatment duration of bortezomib in transplant-ineligible newly diagnosed multiple myeloma.

Biweekly full-dose treatment in the first cycles has a major impact in depth of response. Depth of response, cumulative bortezomib dose, and treatment duration had an impact in prolongation of PFS.